Cargando…
Medullary Thyroid Carcinoma: Molecular Signaling Pathways and Emerging Therapies
Research on medullary thyroid carcinoma (MTC) over the last 55 years has led to a good understanding of the genetic defects and altered molecular pathways associated with its development. Currently, with the use of genetic testing, patients at high risk for MTC can be identified before the disease d...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE-Hindawi Access to Research
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112527/ https://www.ncbi.nlm.nih.gov/pubmed/21687607 http://dx.doi.org/10.4061/2011/815826 |